scispace - formally typeset
P

Peter B. Dirks

Researcher at University of Toronto

Publications -  288
Citations -  37596

Peter B. Dirks is an academic researcher from University of Toronto. The author has contributed to research in topics: Stem cell & Cancer. The author has an hindex of 69, co-authored 252 publications receiving 32672 citations. Previous affiliations of Peter B. Dirks include Hospital for Sick Children & Ontario Institute for Cancer Research.

Papers
More filters
Journal ArticleDOI

Identification of human brain tumour initiating cells

TL;DR: The development of a xenograft assay that identified human brain tumour initiating cells that initiate tumours in vivo gives strong support for the CSC hypothesis as the basis for many solid tumours, and establishes a previously unidentified cellular target for more effective cancer therapies.
Journal Article

Identification of a Cancer Stem Cell in Human Brain Tumors

TL;DR: The identification and purification of a cancer stem cell from human brain tumors of different phenotypes that possesses a marked capacity for proliferation, self-renewal, and differentiation is reported.
Journal ArticleDOI

Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells.

TL;DR: A workshop was convened by the AACR to discuss the rapidly emerging cancer stem cell model for tumor development and progression, and participants were charged with evaluating data suggesting that cancers develop from a small subset of cells with self-renewal properties analogous to organ regeneration.
Journal ArticleDOI

High-Resolution CRISPR Screens Reveal Fitness Genes and Genotype-Specific Cancer Liabilities

TL;DR: It is demonstrated that context-dependent fitness genes accurately recapitulate pathway-specific genetic vulnerabilities induced by known oncogenes and reveal cell-type-specific dependencies for specific receptor tyrosine kinases, even in oncogenic KRAS backgrounds.
Journal ArticleDOI

Cancer stem cells: an evolving concept

TL;DR: New insights are obtained into why the CSC concept is not universally applicable, as well as a new basis for understanding the complex evolution, phenotypic heterogeneity and therapeutic challenges of many human cancers.